Cristobal Barrios, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-8068 Fax: 714-456-3765 |
Dr. Mark Allen Rosen, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Bldg. 53 Room 119, Rt. 81, Orange, CA 92868 Phone: 714-456-5150 |
Joseph C Preston, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 W La Veta Ave Ste 750, Orange, CA 92868 Phone: 714-361-6600 Fax: 714-919-8804 |
Dr. Bahman Saatian, M.D. Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-8026 |
Steven B. Leven, MD Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 333 City Blvd W, Suite 400, Orange, CA 92868 Phone: 562-884-3783 Fax: 714-456-3597 |
Martin Rofael, Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-7890 |
Dr. Lillian Chow, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-880-7812 |
News Archive
A new study by researchers at the Ernest Gallo Clinic and Research Center at UC San Francisco offers encouraging findings that researchers hope may one day lead to a treatment option for people who suffer from alcohol abuse disorders and other addictions.
Scientists at A*STAR's Genome Institute of Singapore (GIS) and the Max Planck Institute for Molecular Genetics (MPIMG) in Berlin (Germany) have discovered a molecular network in human embryonic stem cells (hESCs) that integrates cell communication signals to keep the cell in its stem cell state.
NASA researchers announce a potential cause of rapid kidney stone formation in astronauts on space travels. The authors of a study published in Kidney International call for a "Major Initiative" to investigate nanobacteria.
Medicure Inc., today reported the results of operations for the three months ended August 31, 2009 (Q1 2009/10). All amounts cited below are in Canadian dollars unless otherwise noted.
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® Crohn's Prognostic test. This novel and unique diagnostic represents a significant advance in the Prometheus Inflammatory Bowel Disease (IBD) franchise of diagnostic and prognostic tests, and complements the market-leading PROMETHEUS® IBD Serology 7.
› Verified 9 days ago